Sponsor Pipeline

Advenchen Laboratories Nanjing Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06247605 A Phase IIII Study of AL8326 in Small Cell Lung Cancer Small Cell Lung Carcinoma Recruiting
Phase 1
NCT07179081 A Study of AL58805 in Patients With Advanced Tumors Advanced Tumors Recruiting
NCT07438886 Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers Healthy Volunteer Not Yet Recruiting
Disease Areas
Small Cell Lung Cancer (1) Lung Cancer (1)
Get alerts when Advenchen Laboratories Nanjing Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free